Zhonglin Hao, MD
Medical Oncology · Lexington, KYNPI 1356527543
Payments from drug & device makers
Across 290 payments — averaging $11,922 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$2.2M
- Merck$531K
- E.r. Squibb & Sons, L.L.C.$161K
- Beigene, Ltd.$117K
- Daiichi Sankyo Inc.$89K
- Biontech SE$86K
- plus $258K from 13 others
Across 8 payments — averaging $347.10 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novartis Pharma AG$3K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 7 | $2,215,938 |
| Merck | 40 | $530,814 |
| E.r. Squibb & Sons, L.L.C. | 2 | $160,864 |
| Beigene, Ltd. | 41 | $117,267 |
| Daiichi Sankyo Inc. | 103 | $88,587 |
| Biontech SE | 24 | $86,198 |
| Tersera Therapeutics LLC | 16 | $74,176 |
| Amgen | 4 | $59,503 |
| Beigene Switzerland GmbH | 1 | $40,054 |
| AbbVie | 6 | $29,806 |
| Incyte Corporation | 29 | $20,006 |
| Lexicon Pharmaceuticals, Inc. | 3 | $17,679 |
| AstraZeneca | 8 | $8,159 |
| Array Biopharma Inc | 1 | $4,200 |
| Beone Medicines USA, Inc. | 1 | $3,164 |
| Organon | 1 | $713 |
| Jazz Pharmaceuticals Inc. | 1 | $102 |
| Johnson & Johnson | 1 | $92 |
| Ipsen Biopharmaceuticals, Inc | 1 | $50 |
How this compares
$3,457,373 in reported general payments places this provider in the 90th percentile of 53 medical oncology providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other medical oncology in Lexington
- Susanne ArnoldLexington$5.2M
- Zin MyintLexington$3.4M
- Ralph ZinnerLexington$760K
- Reema PatelLexington$656K
- Lowell AnthonyLexington$520K
- Shawn PetersonLexington$505K
- Peng WangLexington$251K
- Arvinda PadmanabhanLexington$43K
- Ruta AraysLexington$39K
- Robert DipaolaLexington$31K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.